Johnson Craig A Insider Trades

Insider Trading History

Track insider trading activity for Johnson Craig A. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Heron Therapeutics
Heron Therapeutics HRTX
Director
Holding Value $24.1k 53,960 shares
Last Trade
Jan 30, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$71.2k 53,960 shares
$1.32
$0.45
Aurinia Pharmaceuticals
Aurinia Pharmaceuticals AUPH
Director
Holding Value $229k 14,592 shares
Last Trade
Nov 21, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$94.7k 6,039 shares
$15.68
$15.67
Aurinia Pharmaceuticals
Aurinia Pharmaceuticals AUPH
Director
Holding Value $587k 37,485 shares
Last Trade
May 16, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$306k 37,485 shares
$8.15
$15.67
Heron Therapeutics
Heron Therapeutics HRTX
Director
Holding Value $37.4k 83,770 shares
Last Trade
Jan 31, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$61k 35,900 shares
$1.70
$0.45
Heron Therapeutics
Heron Therapeutics HRTX
Director
Holding Value $37.4k 83,770 shares
Last Trade
Jan 30, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$62.1k 35,900 shares
$1.73
$0.45
Aurinia Pharmaceuticals
Aurinia Pharmaceuticals AUPH
Director
Holding Value $497k 31,688 shares
Last Trade
Nov 21, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$261k 31,688 shares
$8.24
$15.67
Mirati Therapeutics
Mirati Therapeutics MRTX
Director
Holding Value $660k 11,252 shares
Last Trade
Jan 23, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$2M 34,021 shares
$58.70
$58.70
Heron Therapeutics
Heron Therapeutics HRTX
Director
Holding Value $37.4k 83,685 shares
Last Trade
Jan 19, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$175k 83,685 shares
$2.09
$0.45
Mirati Therapeutics
Mirati Therapeutics MRTX
Director
Holding Value $1.01M 17,273 shares
Last Trade
Dec 29, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$400k 6,808 shares
$58.75
$58.70
Mirati Therapeutics
Mirati Therapeutics MRTX
Director
Holding Value $614k 10,465 shares
Last Trade
Jan 20, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$546k 11,964 shares
$45.66
$58.70
La Jolla Pharmaceutical
La Jolla Pharmaceutical LJPC
Director
Holding Value $0 0 shares
Last Trade
Aug 22, 2022 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$62.2k 10,000 shares
$6.22
$6.19
La Jolla Pharmaceutical
La Jolla Pharmaceutical LJPC
Director
Holding Value $74.3k 12,000 shares
Last Trade
Jul 08, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$40.7k 12,000 shares
$3.39
$6.19
La Jolla Pharmaceutical
La Jolla Pharmaceutical LJPC
Director
Holding Value $0 0 shares
Last Trade
Jul 08, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$81.4k 24,000 shares
$3.39
$6.19
Mirati Therapeutics
Mirati Therapeutics MRTX
Holding Value $353k 6,021 shares
Last Trade
Jan 14, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$775k 6,234 shares
$124.31
$58.70
La Jolla Pharmaceutical
La Jolla Pharmaceutical LJPC
Director
Holding Value $186k 30,000 shares
Last Trade
Jan 12, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$144k 30,000 shares
$4.81
$6.19
Heron Therapeutics
Heron Therapeutics HRTX
Director
Holding Value $9.34k 20,903 shares
Last Trade
Dec 22, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$205k 20,903 shares
$9.81
$0.45
Heron Therapeutics
Heron Therapeutics HRTX
Director
Holding Value $1.27k 2,840 shares
Last Trade
Dec 21, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.43k 250 shares
$9.73
$0.45
Heron Therapeutics
Heron Therapeutics HRTX
Director
Holding Value $1.38k 3,090 shares
Last Trade
Sep 21, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$3.08k 250 shares
$12.30
$0.45
Heron Therapeutics
Heron Therapeutics HRTX
Director
Holding Value $1.49k 3,340 shares
Last Trade
Jun 21, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$3.8k 250 shares
$15.20
$0.45
Heron Therapeutics
Heron Therapeutics HRTX
Director
Holding Value $1.6k 3,590 shares
Last Trade
Apr 06, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$4.31k 250 shares
$17.22
$0.45

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up